Is Now the Time to Buy Aurora Cannabis (ACB)?

: ACB | Aurora Cannabis Inc. Common Shares News, Ratings, and Charts

ACB – Aurora Cannabis reported its Q1 2020 financial results after the market closed yesterday, Thursday, November 14th, 2019.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Aurora Cannabis reported its Q1 2020 financial results after the market closed yesterday, Thursday, November 14th, 2019. Despite the fact that cannabis stocks had a terrible day because of Canopy Growth’s disappointing earnings release yesterday morning, shares of Aurora Cannabis continued to decline over 10% after hours. 

Aurora Cannabis posted a gross profit of $53.7 Million and 58% Cannabis Gross Margin. Aurora Cannabis generated Total Revenues of $75.6 Million which Included Medical and Consumer Cannabis Net Revenue of $60.5 Million and Wholesale Cannabis Net Revenues of $10.3 Million.

Aurora Cannabis saw a significant decline in revenues due to provincial ordering that slowed down considerably during the summer, as distributors sold through inventories. Also, the industry was impacted by the slow pace of retail store licensing. Canadian consumer cannabis revenues took the biggest hit declining 33% sequentially due to these factors.  

The Canadian government is responsible for causing a bottleneck in cannabis production, which in turn has led to many of the large-cap cannabis stocks, including Aurora Cannabis, to suffer.  This puts many of these cannabis companies in a very tough spot as they ramp up production, yet they are not able to sell their products due to a lack of sales channels. These companies need retail revenues to materialize.

Declines in revenues for two of the largest cannabis companies, Canopy Growth and Aurora Cannabis, on the same day was a double whammy, and their unimpressive results are being felt throughout the marijuna industry.  Just this week, the largest cannabis ETF, ETFMG Alternative Harvest ETF (NYSE:MJ), is trading 13% lower.

Investors want to see a clear path to profitability and growing revenues, which was essentially the opposite of what happened this quarter. However, there is some positive news and potential catalysts on the horizon for Aurora Cannabis: 

  • In yesterday’s report, Aurora Cannabis revealed that their cost per gram sold declined 25% sequentially to $0.85 per gram, which did deliver on the company’s promise to produce under 1 dollar per gram. 
  • They also reported that their market for medicinal marijuana is strong, as revenues increased 3% sequentially and their patient base grew 8% to 91,116 active patients. 
  • Aurora Cannabis ia looking to capitalize on then “cannabis 2.0” market which includes edibles and many different high margin products. 
  • And the rollout of more retail stores across Canada which should also help Aurora Cannabis grow revenues in the near term but this will all depend on how fast the government will allow new stores to open. 

Though the cannabis industry’s performance recently has been quite lackluster, we are still positive for the long-term.  When the Canadian government stops causing a bottleneck in the industry we believe Aurora Cannabis, and its competitors, will be able to grow revenues dramatically.  And we think Aurora Cannabis is positioning themselves to be an industry leader, not only in the Canadian market, but on the international front. 

(Disclosure: The author owns shares of Aurora Cannabis)



ACB shares were trading at $3.12 per share on Friday morning, down $0.17 (-5.17%). Year-to-date, ACB has declined -37.10%, versus a 26.25% rise in the benchmark S&P 500 index during the same period.

About the Author: Aaron Missere

Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...

More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
MJGet RatingGet RatingGet Rating
CRONGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating
CTSTGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Top Stories on

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

Are “False Positives” Pushing Stocks Artificially Higher?

One of the reasons behind the current height of the S&P 500 (SPY) is a false understanding of key pieces of economic data. Steve Reitmeister explains these false positives and why the outlook is still decidedly negative for stocks.
NASDAQ: TSLA | Tesla, Inc. News, Ratings, and Charts

Betting Against Tesla Has Failed and Failed and Failed Again

I’ve long been an admirer of the medical technology company Becton Dickinson & Co. (BDX), which I think of being the anti-Tesla.
NYSE: CMG | Chipotle Mexican Grill, Inc.  News, Ratings, and Charts

4 Mouth-Watering Restaurant Stocks to Buy Now

The Restaurant industry struggling during the pandemic, and many won't survive. However, this is benefiting Chipotle Mexican Grill (CMG), Domino's Pizza (DPZ), Wingstop (WING), and Papa John's (PZZA) who are gaining market share.
NASDAQ: TSLA | Tesla, Inc. News, Ratings, and Charts

3 Electric Vehicle Stocks to Supercharge Your Portfolio

Electric vehicle stocks are in the midst of a massive bull market. Tesla (TSLA), Nio (NIO), and Plug Power (PLUG) are three big winners.
: SNAP | Snap Inc.  News, Ratings, and Charts

3 VR and AR Stocks With Major Potential

VR and AR are exciting future technologies that will be as transformational as the Internet and smartphones. Snap (SNAP), Himax Technologies (HIMX), and Vuzix (VUZI) are three companies to play this trend.

Read More Stories

More Aurora Cannabis Inc. Common Shares (ACB) News View All

Event/DateSymbolNews DetailStart PriceEnd PriceChangePOWR Rating
Loading, please wait...
View All ACB News